{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T04:28:29Z","timestamp":1780374509826,"version":"3.54.1"},"reference-count":125,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2012,1,24]],"date-time":"2012-01-24T00:00:00Z","timestamp":1327363200000},"content-version":"vor","delay-in-days":10665,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["accpjournals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Pharmacotherapy"],"published-print":{"date-parts":[[1982,11,12]]},"abstract":"<jats:p>The acylureido penicillin mezlocillin is active against gram\u2010positive, gram\u2010negative, and anaerobic bacteria. It easily penetrates the outer membrane of gram\u2010negative bacteria, and it has a strong affinity for penicillin binding protein 3. Its stability to 3\u2010lactamases is weak. Mezlocillin is synergistic when given in combination with aminoglycoside antibiotics. In pharmacokinetic studies mezlocillin conforms to a two compartment open model; its pharmacokinetic properties are dose\u2010dependent. The half\u2010life of the drug is about 1 hour after intravenous injection and 1.5 hours after intramuscular injection. Protein binding ranges from 16 to 42%, and 55% of a dose is excreted in the urine. Biliary excretion ranges from 0.5 to 25%. Clinical trial cure rates were as follows: bacteremia (78%), respiratory tract (62%), urinary tract (81%), gynecological (86%), bone and joint (55%), intraabdominal (67%) and skin and soft tissue (59%). The frequency of adverse reactions was 7.7%. Interstitial nephritis, CNS toxicity, and bleeding have not been reported.<\/jats:p>","DOI":"10.1002\/j.1875-9114.1982.tb03204.x","type":"journal-article","created":{"date-parts":[[2015,12,16]],"date-time":"2015-12-16T08:26:23Z","timestamp":1450254383000},"page":"300-310","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Microbiology, Pharmacology, and Clinical Use of Mezlocillin Sodium"],"prefix":"10.1002","volume":"2","author":[{"given":"Richard V.","family":"McCloskey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack L.","family":"LeFrock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce R.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George R.","family":"Aronoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2012,1,24]]},"reference":[{"key":"e_1_2_1_2_2","first-page":"38","volume-title":"Morphological changes in bacteria after treatment with acylureidopenicillins","author":"Voigt W.","year":"1980"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/1.3.434"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.19.2.359"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.13.6.930"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.11.1.74"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.16.2.115"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.3949\/ccjm.47.4.311"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.14.4.549"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.15.3.487"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.15.4.540"},{"key":"e_1_2_1_12_2","first-page":"1929","article-title":"Azlocillin and mezlocillin, two new beta\u2010amino\u2010substituted penicillins","volume":"29","author":"Wise R.","year":"1979","journal-title":"Arzneimittelforsch."},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.15.6.783"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.15.3.396"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.13.5.813"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1159\/000237772"},{"key":"e_1_2_1_17_2","first-page":"1934","article-title":"Synergistic action between sisomicin and mezlocillin against gram\u2010negative bacteria and Staphylococcus aureus","volume":"29","author":"Soares K","year":"1979","journal-title":"Arzneimittelforsch."},{"key":"e_1_2_1_18_2","first-page":"1916","article-title":"Antibacterial activity of mezlocillin and azlocillin \u2014 a survey","volume":"29","author":"Knothe V.","year":"1979","journal-title":"Arzneimittelforsch."},{"key":"e_1_2_1_19_2","first-page":"1920","article-title":"Azlocillin and mezlocillin: laboratory studies of their properties, including comparison with the antibacterial activity of other antibiotics","volume":"29","author":"Reeves D","year":"1979","journal-title":"Arzneimittelforsch."},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/5.3.301"},{"key":"e_1_2_1_21_2","unstructured":"WernerH KrasemannC AngerechtsJ.The Activity of mezlocillin against bacteroidaceae compared with the activities of ticarcillin cefoxitin cefotaxime clindamycin and metronidazole. See reference 1 pp17\u201321."},{"key":"e_1_2_1_22_2","unstructured":"WegnerLA SchachtP ForsterD.Bile\u2010kinetic investigations with mezlocillin BAY F1353 on human subjects (study 114) [Interim Report]. Translated from Pharma\u2010Report no. 6382. Wuppertal W. Germany. Bayer AG.1976."},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.13.6.930"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01641306"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/5.5.517"},{"key":"e_1_2_1_26_2","first-page":"1769","article-title":"Pharmacokinetische Untersuchungen mit Breitspektrum\u2010Penicillin\/Oxacillin\u2010Kombinations bei freiwilligen Probanden","volume":"29","author":"Adam D","year":"1979","journal-title":"Arzneimittelforsch."},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.14.6.801"},{"key":"e_1_2_1_28_2","unstructured":"CanoJP.Mezlocillin 5 g \u2014 pharmacokinetics. See reference 21 report no. 1622 1979."},{"key":"e_1_2_1_29_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01639753"},{"key":"e_1_2_1_30_2","volume-title":"Statistical evaluation of pharmacokinetic assay venous mezlocillin in healthy volunteers (Memo D166)","author":"Ordille CM.","year":"1976"},{"key":"e_1_2_1_31_2","doi-asserted-by":"publisher","DOI":"10.1002\/cpt1978241108"},{"key":"e_1_2_1_32_2","unstructured":"GauW TettenbornD.Renal excretion of mezlocillin and its principal metabolite penicilloate. See reference 21 report no. 7938 1978."},{"key":"e_1_2_1_33_2","unstructured":"GraberH ArrH CsibaA.Biotransformation of azlocillin and mezlocillin. See reference 1 pp75\u20137."},{"key":"e_1_2_1_34_2","first-page":"1962","article-title":"Mezlocillin pharmacokinetics \u2014 comparison with ampicillin and influence of probenecid","volume":"29","author":"Verbist L","year":"1979","journal-title":"Arzneimittelforsch."},{"key":"e_1_2_1_35_2","unstructured":"SchachtP KlemenM.BAYPEN (mezlocillin) clinical testing: summary of the results of the clinical testing and of the pharmacokinetic studies with intramuscular mezlocillin. See reference 21 report no. 8448 1979."},{"key":"e_1_2_1_36_2","first-page":"1958","article-title":"Comparison between the pharmacokinetic properties of mezlocillin when given as a bolus injection or as an infusion","volume":"29","author":"Ohlsson H","year":"1979","journal-title":"Arzneimittelforsch."},{"key":"e_1_2_1_37_2","first-page":"1221","volume-title":"Current chemotherapy and infectious disease","author":"Gladtke E","year":"1980"},{"key":"e_1_2_1_38_2","unstructured":"HeimannG.Pharmacokinetics of azlocillin and mezlocillin in prematures and neonates. See reference 1 pp57\u201366."},{"key":"e_1_2_1_39_2","unstructured":"ElliottP ReevesD BywaterM.Clinical trial of mezlocillin a new acylureidopenicillin in lower respiratory infections. In: Current chemotherapy and infectious disease. Proceedings of the 11th international conference of chemotherapy and the 19th interscience conference on antimicrobial agents and chemotherapy Boston.1980:1045\u20137."},{"key":"e_1_2_1_40_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.13.2.180"},{"key":"e_1_2_1_41_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/9.suppl_A.65"},{"key":"e_1_2_1_42_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.18.1.69"},{"key":"e_1_2_1_43_2","unstructured":"DornerM BrogardJM.Report on expert pharmacological investigation made on mezlocillin. See reference 21 report no. 1529 1978."},{"key":"e_1_2_1_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(79)90729-0"},{"key":"e_1_2_1_45_2","doi-asserted-by":"publisher","DOI":"10.1177\/003693307802300311"},{"key":"e_1_2_1_46_2","unstructured":"ModaiJ PierreJ Bergogne\u2010BerezinEet al.Cerebrospinal fluid penetration of mezlocillin. See reference 1 pp1967\u20139."},{"key":"e_1_2_1_47_2","unstructured":"ModaiJ AvrilMF ManuelCHet al.Evaluation of mezlocillin therapy of patients with bacterial meningitis. See reference 36 pp1024\u20136."},{"key":"e_1_2_1_48_2","first-page":"1967","article-title":"Cerebrospinal fluid penetration of mezlocillin","volume":"29","author":"Modai J","year":"1979","journal-title":"Arzneimittelforsch"},{"key":"e_1_2_1_49_2","first-page":"2001","article-title":"Treatment of childhood meningitis with mezlocillin","volume":"29","author":"Llorens\u2010Terol J","year":"1979","journal-title":"Arzneimittelforsch."},{"key":"e_1_2_1_50_2","unstructured":"Bergogne\u2010BerezinE EvenP PierreJet al.Penetration of mezlocillin into bronchial secretions. See reference 1 pp87\u201392."},{"key":"e_1_2_1_51_2","unstructured":"EvenP Bergogne\u2010BerezinE PierreJ.Study of the bronchial penetration of mezlocillin. See reference 21 report no. 1617."},{"key":"e_1_2_1_52_2","first-page":"149","article-title":"Laboratory and clinical studies with mezlocillin. Chemotherapy","volume":"27","author":"Nakagawa K","year":"1979","journal-title":"Jpn"},{"key":"e_1_2_1_53_2","first-page":"112","article-title":"Mezlocillin zur gewebekonzentration and wirksamkeit","volume":"74","author":"Helwing E","year":"1979","journal-title":"Med Klin."},{"key":"e_1_2_1_54_2","unstructured":"MunselJ SchassanH.Concentrations of mezlocillin in tonsillar tissue. See reference 1 pp93\u20134."},{"key":"e_1_2_1_55_2","unstructured":"FederspilP TieslerE WilhelmH.Clinical and pharmacokinetic studies of mezlocillin otorhinolaryngology. See reference 1 pp136\u201343."},{"key":"e_1_2_1_56_2","first-page":"1989","article-title":"Experimental and clinical investigations with mezlocillin in ophthalmology","volume":"29","author":"Oishi M","year":"1979","journal-title":"Arzneimittelforsch."},{"key":"e_1_2_1_57_2","unstructured":"KalmarP KrebberH Muller\u2010SchwefeCKet al.Concentrations of mezlocillin in tissue and serum during extracorporeal circulation. See reference 1 p96."},{"key":"e_1_2_1_58_2","unstructured":"SchachtP ForsterD SalmenHG.Mezlocillin \u2014 determination of tissue levels in the prostate. See reference 21 report no. 8348 1979."},{"key":"e_1_2_1_59_2","unstructured":"AdamD RothH.Capacity of mezlocillin to diffuse into the prostatic tissue. See reference 1 pp99\u2013102."},{"key":"e_1_2_1_60_2","unstructured":"WewalkaG EndlerM KraftA.Concentration of mezlocillin in wound secretions. See reference 1 pp81\u20134."},{"key":"e_1_2_1_61_2","first-page":"85","volume-title":"Peritonitis","author":"Wittmann D","year":"1979"},{"key":"e_1_2_1_62_2","first-page":"1969","article-title":"Mezlocillin\u2010hozentrationen im menschlichen knochen","volume":"29","author":"Vent V.","year":"1979","journal-title":"Arzneimittelforsch."},{"key":"e_1_2_1_63_2","unstructured":"WittmanD SchassanH SchreinerP.Pharmacokinetic investigations into the penetration of azlocillin and mezlocillin into bone and wound tissue fluid. See reference 1 pp85\u20136."},{"key":"e_1_2_1_64_2","unstructured":"VonKobyletzkiD SasM BerkenberyBWet al.Pharmacokinetic investigations of the administration of mezlocillin in gynecology. In: First international symposium on acylureido\u2010penicillins. Stuttgart 1978."},{"key":"e_1_2_1_65_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.16.5.651"},{"key":"e_1_2_1_66_2","doi-asserted-by":"publisher","DOI":"10.1002\/cpt1979262228"},{"key":"e_1_2_1_67_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1980.197"},{"key":"e_1_2_1_68_2","unstructured":"KampfD SchurigR WeihermullerKet al.Pharmacokinetics of azlocillin and mezlocillin in patients with chronic kidney failure and hemodialysis or peritoneal dialysis. See reference 1 pp53\u20136."},{"key":"e_1_2_1_69_2","first-page":"1960","article-title":"Elimination kinetics of mezlocillin in normal and impaired renal function including the effects of dialysis","volume":"29","author":"Kosmidis J","year":"1979","journal-title":"Arzneimittelforsch."},{"key":"e_1_2_1_70_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.17.4.599"},{"key":"e_1_2_1_71_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.18.1.81"},{"key":"e_1_2_1_72_2","first-page":"48","volume-title":"Mezlin formulary data","author":"Pharmaceuticals Miles","year":"1981"},{"key":"e_1_2_1_73_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.13.4.559"},{"key":"e_1_2_1_74_2","unstructured":"ElliottPJ ReevesDS BywaterMJ.Clinical trial of mezlocillin a new ureidopenicillin in lower respiratory infections. See reference 1 pp127\u201332."},{"key":"e_1_2_1_75_2","first-page":"293","volume-title":"Current chemotherapy and infectious disease","author":"Spicehandler JR","year":"1980"},{"key":"e_1_2_1_76_2","unstructured":"TettenbornD BruckH DyckaJet al.Results of large scale clinical studies with mezlocillin. See reference 1 pp188\u201393."},{"key":"e_1_2_1_77_2","first-page":"2009","article-title":"Clinical results with mezlocillin","volume":"12","author":"Tettenborn D","year":"1979","journal-title":"Arzneimittelforsch."},{"key":"e_1_2_1_78_2","unstructured":"NishimuraT.Clinical comparative double blind study with mezlocillin and ampicillin in the treatment of bacterial pneumonia in children. See reference 1 pp123\u20136."},{"key":"e_1_2_1_79_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/9.suppl_A.209"},{"key":"e_1_2_1_80_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(79)90729-0"},{"key":"e_1_2_1_81_2","first-page":"1045","volume-title":"Current chemotherapy and infectious disease","author":"Elliott PJ","year":"1980"},{"key":"e_1_2_1_82_2","first-page":"1995","article-title":"Antibiotic therapy of infections in patients under surgical intensive care, in particular with mezlocillin","volume":"12","author":"Haldemann G","year":"1979","journal-title":"Arzneimittelforsch."},{"key":"e_1_2_1_83_2","first-page":"2003","article-title":"Therapy of pneumonia in children with mezlocillin","volume":"12","author":"Weippl G.","year":"1979","journal-title":"Arzneimittelforsch."},{"key":"e_1_2_1_84_2","unstructured":"FederspilP TieslerE WilhelmHJ.Clinical and pharmacokinetic studies on mezlocillin in otorhinolaryngology. See reference 1 pp136\u201343."},{"key":"e_1_2_1_85_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/9.suppl_A.193"},{"key":"e_1_2_1_86_2","article-title":"Results of a prospective double blind comparison of mezlocillin and ticarcillin for treatment of skin, bone, and soft tissue infections","author":"McCloskey RV.","journal-title":"Curr Chemother Infect Dis"},{"key":"e_1_2_1_87_2","unstructured":"DeckerK FleinerR.The treatment of infections in obstetrics and gynaecology with mezlocillin. See reference 1 pp149\u201351."},{"key":"e_1_2_1_88_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/9.suppl_A.159"},{"key":"e_1_2_1_89_2","first-page":"1999","article-title":"Studies on the efficacy and toler\u2010ability of mezlocillin in female patients suffering from gynaecologic obstetric infections","volume":"12","author":"Weissenbacher ER","year":"1979","journal-title":"Arzneimittelforsch."},{"key":"e_1_2_1_90_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/9.suppl_A.199"},{"key":"e_1_2_1_91_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/9.suppl_A.149"},{"key":"e_1_2_1_92_2","unstructured":"CunhaACM LimaGR MelloBet al.Post\u2010abortion and puerperal infections: treatment with mezlocillin. See reference 36 pp1221\u20133."},{"key":"e_1_2_1_93_2","unstructured":"RauhG SonnabendW.Mezlocillin combined with aminoglycoside in fecal infections. See reference 1 pp166\u20138."},{"key":"e_1_2_1_94_2","doi-asserted-by":"crossref","unstructured":"LeFrockJ MolaviA RolstonKet al.Comparative clinical evaluation of mezlocillin and cefoxitin in intraabdominal and pelvic infections (abstract). In: Proceedings of 22nd interscience conference on antimicrobial agents and chemotherapy Miami October 1982 in press.","DOI":"10.1093\/jac\/9.suppl_A.199"},{"key":"e_1_2_1_95_2","first-page":"31","volume-title":"Mezlocillin in acute abdominal surgery (abstract)","author":"Staeban CJL","year":"1982"},{"key":"e_1_2_1_96_2","unstructured":"PetersHJ WeisbachL NuriM.Comparative clinical multicentric trial of the efficacy of mezlocillin and of cefuroxime in patients with infections of the urinary tract. See reference 1 pp161\u20135."},{"key":"e_1_2_1_97_2","first-page":"1992","article-title":"Mezlocillin in the treatment of urinary tract infections","volume":"12","author":"Almeida TR","year":"1979","journal-title":"Arzneimittelforsch."},{"key":"e_1_2_1_98_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/9.suppl_A.179"},{"key":"e_1_2_1_99_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/9.suppl_A.125"},{"key":"e_1_2_1_100_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/9.suppl_A.173"},{"key":"e_1_2_1_101_2","first-page":"2001","article-title":"Treatment of childhood meningitis with mezlocillin","volume":"12","author":"Lloren\u2010Terol J","year":"1979","journal-title":"Arzneimittelforsch."},{"key":"e_1_2_1_102_2","unstructured":"GrenierB DruckerJ BorderonJC.Clinical efficacy of mezlocillin in children with normal renal function (abstract). See reference 94 p51."},{"key":"e_1_2_1_103_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.17.6.1008"},{"key":"e_1_2_1_104_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.18.2.299"},{"key":"e_1_2_1_105_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/7.6.657"},{"key":"e_1_2_1_106_2","first-page":"2028","article-title":"Therapy with an antibiotic combination mezlocillin\/oxacillin and clinical experience\/second communication: children","volume":"12","author":"Chysky V","year":"1979","journal-title":"Arzneimittelforsch."},{"key":"e_1_2_1_107_2","unstructured":"IssellBF BodeyGP.Mezlocillin for gram\u2010negative bacillary infections in cancer patients. See reference 36 pp1461\u20133."},{"key":"e_1_2_1_108_2","first-page":"2021","article-title":"Therapy with an antibiotic combination mezlocillin\/oxacillin and clinical experience\/first communication: adults","volume":"12","author":"Chysky V","year":"1979","journal-title":"Arzneimittelforsch."},{"key":"e_1_2_1_109_2","unstructured":"LaChevallerieBV.Experience with mezlocillin in pediatrics. See reference 1 pp110\u20136."},{"key":"e_1_2_1_110_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/9.suppl_A.257"},{"key":"e_1_2_1_111_2","unstructured":"BehreU.Mono and combined treatment with mezlocillin in pediatrics (abstract). See reference 94 p49."},{"key":"e_1_2_1_112_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/9.suppl_A.223"},{"key":"e_1_2_1_113_2","unstructured":"Kahan\u2010CoppensL KlasterskyJ.Clinical evaluation of mezlocillin plus sisomicin as empirical treatment of gram\u2010negative bacterial infections. See reference 1 pp144\u20138."},{"key":"e_1_2_1_114_2","unstructured":"Hernandez\u2010LopezJM PichardoRA AndradeLHet al.Mezlocillin vs mezlocillin and metronidazole in abdominal surgery with suspected anaerobic infections (traumatic colon injuries) (abstract). See reference 94 p37."},{"key":"e_1_2_1_115_2","unstructured":"WensalM WaldenM.The systemic prophylaxis with mezlocillin in elective surgery of the colon (abstract). See reference 94 p35."},{"key":"e_1_2_1_116_2","unstructured":"GruberUF GerberH ElkeRet al.Prophylactic use of mezlocillin in biliary tract surgery (abstract). See reference 94 p 29."},{"key":"e_1_2_1_117_2","unstructured":"KutheP ScheeleR WoratzMet al.Is prophlactic administration of mezlocillin for vaginal hysterectomy justified?See reference 1 pp152\u20136."},{"key":"e_1_2_1_118_2","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/jac\/9.suppl_A.23","article-title":"The efficacy of mezlocillin in the therapy of bacteremia","volume":"9","author":"Neu HC.","year":"1982","journal-title":"J Antimicrob Chemother."},{"key":"e_1_2_1_119_2","doi-asserted-by":"publisher","DOI":"10.1185\/03007997909109015"},{"key":"e_1_2_1_120_2","first-page":"191","article-title":"Mezlocillin in the treatment of gonorrhea","author":"Lassus A","year":"1979","journal-title":"Br J Vener Dis."},{"key":"e_1_2_1_121_2","unstructured":"BirkettJP.Mezlocillin summary of clinical results U.S.A. (abstract). See reference 94 p57."},{"key":"e_1_2_1_122_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/9.suppl_A.267"},{"key":"e_1_2_1_123_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/9.suppl_A.273"},{"key":"e_1_2_1_124_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.16.5.605"},{"key":"e_1_2_1_125_2","first-page":"1985","article-title":"Local tolerance of intramuscular mezlocillin","volume":"29","author":"Belli L","year":"1979","journal-title":"Arzneimittelforsch."},{"key":"e_1_2_1_126_2","first-page":"1167","article-title":"In vitro inactivation of gentamicin, tobramycin and netilmicin by carbencillin, azlocillin and mezlocillin","volume":"39","author":"Henderson J","year":"1981","journal-title":"Am J Hosp Pharm."}],"container-title":["Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fj.1875-9114.1982.tb03204.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fj.1875-9114.1982.tb03204.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/accpjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/j.1875-9114.1982.tb03204.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T11:48:37Z","timestamp":1761047317000},"score":1,"resource":{"primary":{"URL":"https:\/\/accpjournals.onlinelibrary.wiley.com\/doi\/10.1002\/j.1875-9114.1982.tb03204.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1982,11,12]]},"references-count":125,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1982,11,12]]}},"alternative-id":["10.1002\/j.1875-9114.1982.tb03204.x"],"URL":"https:\/\/doi.org\/10.1002\/j.1875-9114.1982.tb03204.x","archive":["Portico"],"relation":{},"ISSN":["0277-0008","1875-9114"],"issn-type":[{"value":"0277-0008","type":"print"},{"value":"1875-9114","type":"electronic"}],"subject":[],"published":{"date-parts":[[1982,11,12]]},"assertion":[{"value":"2012-01-24","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}